Fortify Ventures

Fortify Ventures' investment decisions are made by its partnership team, which includes a Managing Partner and at least one General Partner. The firm's website indicates that these operators are deep industry experts with experience as both entrepreneurs and investors, though individual names and bios are not publicly listed.

Fortify invests in technology that measurably improves human performance — helping people feel better, function better, and perform better. The firm targets early-stage companies building consumer-centric products anchored in real-world behavior, with a preference for hardware-enabled experiences where software amplifies the physical product. It explicitly avoids biotech, pharma, medical devices, and enterprise clinical workflow tools.

The firm's primary focus is the United States, requiring portfolio companies to be formed as Delaware C-Corps. It also evaluates select opportunities in Europe and Israel. Fortify maintains physical offices in Ashburn, Virginia and Los Angeles, California.

Distilled Intelligence is Fortify's proprietary annual summit that curates collisions among founders, operators, and investors. The most recent edition hosted 100 startups and hundreds of attendees, with Fortify directly providing over $1 million in funding to participating companies. It serves as a centralized sourcing, branding, and community-building engine for the firm.

Fortify is comfortable leading rounds but does not require it. The firm prioritizes the quality of the company and its ability to be an effective partner. It targets a 7% ownership stake with its initial check and will only invest when there is enough capital committed to act as a clear catalyst for growth, avoiding rolling rounds that lack a defined milestone.

Fortify's mandate is exclusively focused on human health and performance technology. It will only invest in products used by people that drive real improvements in health or performance, whether that is direct-to-consumer, B2B benefiting employees, or a marketplace. Enterprise infrastructure, clinical workflow tools, biotech, pharma, and medical devices are all explicitly outside the firm's investment scope.

Both current and prospective limited partners can reach out to Fortify directly at IR@fortify.vc. The firm maintains a dedicated LP relations function and commits to having the appropriate team member respond.